<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20031101//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">3324410</article-id><article-id pub-id-type="pmid">22509378</article-id><article-id pub-id-type="publisher-id">PONE-D-12-03731</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0035041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Population Genetics</subject><subj-group><subject>Genetic Polymorphism</subject></subj-group></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Human Genetics</subject><subj-group><subject>Genetic Association Studies</subject></subj-group></subj-group><subj-group><subject>Genome-Wide Association Studies</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Epidemiology</subject></subj-group><subj-group><subject>Obstetrics and Gynecology</subject><subj-group><subject>Sexual Dysfunction</subject></subj-group></subj-group><subj-group><subject>Women's Health</subject></subj-group></subj-group></article-categories><title-group><article-title>A Genome-Wide Association Study of Female Sexual Dysfunction</article-title><alt-title alt-title-type="running-head">GWAS on FSD</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Burri</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hysi</surname><given-names>Pirro</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Clop</surname><given-names>Alex</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rahman</surname><given-names>Qazi</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Spector</surname><given-names>Tim D.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Biological and Experimental Psychology Group, School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Department of Twin Research and Genetic Epidemiology, King&#8217;s College London, London, United Kingdom</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Medical and Molecular Genetics, School of Medicine, King's College London, London, United Kingdom</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Huang</surname><given-names>Qingyang</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Central China Normal University, China</aff><author-notes><corresp id="cor1">* E-mail: <email>andrea.burri@kcl.ac.uk</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: AB PH TS AC. Performed the experiments: AB PH. Analyzed the data: AB PH. Wrote the paper: AB QR.</p></fn></author-notes><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>11</day><month>4</month><year>2012</year></pub-date><volume>7</volume><issue>4</issue><elocation-id>e35041</elocation-id><history><date date-type="received"><day>7</day><month>2</month><year>2012</year></date><date date-type="accepted"><day>8</day><month>3</month><year>2012</year></date></history><permissions><copyright-statement>Burri et al.</copyright-statement><copyright-year>2012</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Female sexual dysfunction (FSD) is an important but controversial problem with serious negative impact on women&#8217;s quality of life. Data from twin studies have shown a genetic contribution to the development and maintenance of FSD.</p></sec><sec><title>Methodology/Principal Findings</title><p>We performed a genome-wide association study (GWAS) on 2.5 million single-nucleotide polymorphisms (SNPs) in 1,104 female twins (25&#8211;81 years of age) in a population-based register and phenotypic data on lifelong sexual functioning. Although none reached conventional genome-wide level of significance (10&#215;-8), we found strongly suggestive associations with the phenotypic dimension of arousal (rs13202860, <italic>P&#8202;=&#8202;</italic>1.2&#215;10<sup>&#8722;7</sup>; rs1876525, <italic>P</italic>&#8202;=&#8202;1.2&#215;10<sup>&#8722;7</sup>; and rs13209281 <italic>P</italic>&#8202;=&#8202;8.3&#215;10<sup>&#8722;7</sup>) on chromosome 6, around 500kb upstream of the locus <italic>HTR1E</italic> (5-hydroxytryptamine receptor 1E) locus, related to the serotonin brain pathways. We could not replicate previously reported candidate SNPs associated with FSD in the <italic>DRD4</italic>, <italic>5HT2A</italic> and <italic>IL-1B</italic> loci.</p></sec><sec><title>Conclusions/Significance</title><p>We report the first GWAS of FSD symptoms in humans. This has pointed to several &#8220;risk alleles&#8221; and the implication of the serotonin and GABA pathways. Ultimately, understanding key mechanisms via this research may lead to new FSD treatments and inform clinical practice and developments in psychiatric nosology.</p></sec></abstract><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>People vary in their enjoyment of sexual activity and relationships &#8211; a source of significant mental wellbeing or problems. Female sexual dysfunction (FSD) describes a cluster of sexual symptoms including desire, arousal, orgasm and pain. It appears relatively common in the general community and population-level samples and is associated with a severe decrease in quality of life in women <xref rid="pone.0035041-Laumann1" ref-type="bibr">[1]</xref>&#8211;<xref rid="pone.0035041-Burri1" ref-type="bibr">[3]</xref>. The etiology of FSD is largely unknown although several biological and psychological correlates have been reported <xref rid="pone.0035041-Burri1" ref-type="bibr">[3]</xref>&#8211;<xref rid="pone.0035041-Hawton1" ref-type="bibr">[5]</xref>. Nevertheless, no clear disease mechanisms have emerged and this lack of knowledge has hampered progress in both, psychiatric nosology and treatment strategies for this growing burden on women&#8217;s psychiatric health. Both, the <italic>Diagnostic and Statistical Manual of Mental Disorders, 4th Edition</italic> and <italic>International Classification of Diseases, Tenth Revision</italic>
<xref rid="pone.0035041-Basson1" ref-type="bibr">[6]</xref> have arranged FSD into categories based largely on clinical similarities, while in 1998 a consensus based definition and classification system was designed by a panel of experts during the International Consensus Development <xref rid="pone.0035041-Basson2" ref-type="bibr">[7]</xref>.</p><p>Biological research into FSD is woefully inadequate. Recent twin studies suggest FSD is familial, with genetic factors accounting for up to 51% of the phenotypic variance <xref rid="pone.0035041-Witting1" ref-type="bibr">[8]</xref>&#8211;<xref rid="pone.0035041-Dunn1" ref-type="bibr">[10]</xref>. Twin studies also show evidence of genetic and environmental contributions to psychological factors previously linked to FSD (such as depression, anxiety, personality traits) <xref rid="pone.0035041-Hettema1" ref-type="bibr">[11]</xref>&#8211;<xref rid="pone.0035041-Jang1" ref-type="bibr">[13]</xref>. Thus, it is possible that some of the covariation between FSD and these psychological correlates is explained by shared genetic and non-genetic factors. However, there have been no large-scale studies to identify single genes or gene variants robustly associated with FSD-phenotypes (and no genome-wide association study - GWAS - has ever been performed). To date, only a handful of candidate gene studies of sexual desire and function exist. One candidate gene study has linked serotonin polymorphisms (<italic>5HT2A</italic>) to reduced sexual desire as a side-effect of SSRI-medication in 89 adult men and women <xref rid="pone.0035041-Bishop1" ref-type="bibr">[14]</xref>. A further study reported an association between the dopamine D4 receptor gene (<italic>DRD4</italic>) with self-reports of sexual desire and arousal in 52 men and 92 women <xref rid="pone.0035041-BenZion1" ref-type="bibr">[15]</xref>. Interleukin-1beta gene (<italic>IL-1B</italic>) has been correlated with variation in vulvar vestibulitis syndrome scores, a broader phenotype for sexual pain symptoms <xref rid="pone.0035041-Gerber1" ref-type="bibr">[16]</xref>. All these studies have methodological shortcomings that limit their interpretation, primarily the candidate gene design, small samples in mostly clinical populations (thus lacking power to detect phenotype &#8211; DNA variant associations), and the use of non-standardized instruments that lack coverage of the phenotypic heterogeneity in sexual function. Moreover, none of these studies examine women and FSD directly, making them unsuitable for clarifying the etiological mechanisms under FSD at the population-level.</p><p>We present here the results of the first GWAS of FSD in a female population-sample published to date. By scanning a dense set of genetic variants throughout the whole genome, we can test replication of previously located genes from candidate gene investigations and also identify novel genes that may lead to the discovery of unknown biological pathways involved in the development of FSD.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Participants</title><p>The TwinsUK adult twin registry based at St. Thomas&#8217; Hospital in London is a volunteer cohort of over 10,000 twins from the general population <xref rid="pone.0035041-Spector1" ref-type="bibr">[17]</xref>. This twin population has been involved in a wide range of studies on common traits and diseases and has been shown to be representative of the general population for a wide variety of medical, behavioral, and sexual traits <xref rid="pone.0035041-Burri1" ref-type="bibr">[3]</xref>, <xref rid="pone.0035041-Andrews1" ref-type="bibr">[18]</xref>, <xref rid="pone.0035041-Snieder1" ref-type="bibr">[19]</xref>. The twins were not selected on the basis of the phenotypes being studied and were unaware of any hypothesis being tested. All twins provided written informed consent and the study was approved by St. Thomas&#8217; Hospital Research Ethics Committee.</p><p>All participants were dizygotic (DZ) pairs and monozygotic (MZ) singleton twins of white European ancestry. A total of 1,489 subjects were included, all sexually active, heterosexual with no history of any major psychological or medical condition (depression, bipolar disorder, anxiety disorder, diabetes, multiple sclerosis, endometriosis) and with all items on the Female Sexual Function Index-Lifelong (FSFI-LL) available.</p></sec><sec id="s2b"><title>Sexual Dysfunction Phenotype</title><p>We used the recently developed 19-item Female FSFI-LL questionnaire to measure long-term variation in female sexuality, including periods of dysfunction and healthy function <xref rid="pone.0035041-Rosen2" ref-type="bibr">[20]</xref>, <xref rid="pone.0035041-Burri2" ref-type="bibr">[21]</xref>. For genetic analysis, the FSFI-LL is preferable to the &#8220;snapshot&#8221; measures used in some previous research and it better captures the variation in <italic>enduring</italic> female sexual functioning required for resolving the underlying genetic and non-genetic mechanisms of FSD symptoms. The FSFI-LL assesses 6 dimensions of women&#8217;s average sexual functioning &#8220;since they have been sexually active&#8221; including desire (2 items), arousal (4 items), lubrication (4 items), orgasm (3 items), satisfaction (3 items), and pain (3 items). Desire items are rated on a Likert-type scale ranging from 1 to 5. The remaining items are rated from 0 to 5 with the supplementary option &#8220;no sexual activity&#8221;. Dimension scores are derived by summing the item scores within each dimension and multiplying the sum by the dimension factor weight <xref rid="pone.0035041-Rosen2" ref-type="bibr">[20]</xref>. The dimension factor weighting converts the dimension scores to a consistent range from 0 to 6, except for the desire, which has a dimension score range from 1.2 to 6. Total scores are calculated via a simple computer algorithm and low scores on the FSFI-LL indicate more sexual problems and high scores indicate fewer problems. The FSFI-LL has excellent psychometric properties for both, total- and dimensions-specific scores, including test-retest reliability, internal consistency, external/discriminant validity <xref rid="pone.0035041-Rosen2" ref-type="bibr">[20]</xref>, <xref rid="pone.0035041-Burri2" ref-type="bibr">[21]</xref>. Exploratory and confirmatory factor analyses have successfully reproduced the original factor. According to response operator curve (ROC)-derived cut-off scores, all dimensions and the total FSD score displayed a good sensitivity to 1-specificity profile (as measured by the area under the curve&#8202;=&#8202;AUC), with arousal (AUC&#8202;=&#8202;0.92) displaying the best trade-off and desire the lowest (AUC&#8202;=&#8202;67.55%). Overall, the FSFI-LL demonstrates excellent comparability to the standard FSFI in terms of factor structure and psychometric properties <xref rid="pone.0035041-Burri2" ref-type="bibr">[21]</xref>.</p><p>Detailed information on prevalences, potential environmental risk factors and heritability estimates for FSD-symptoms in this panel are reported elsewhere (3).</p></sec><sec id="s2c"><title>Genotyping, Quality Control, and Imputation</title><p>Genotyping was carried out using two genotyping platforms from Illumina: the HumanHap 300k Duo for a part of the TwinsUK Cohort (n&#8202;=&#8202;505) and the HumanHap610-Quad array for the remainder of the TwinsUK Cohort (n&#8202;=&#8202;599). Genotyping with the HumanHap 300k Duo was conducted at the Centre National de G&#233;notypage, Duke University, NC, USA; Helsinki University, Finland; and the Wellcome Trust Sanger Institute, Cambridge, UK. Genotyping with the Infinium 610k assay (Illumina, Inc., San Diego, USA) for the remaining individuals was conducted at the Centre for Inherited Diseases Research (USA) and the Wellcome Trust Sanger Institute.</p><p>We applied stringent quality control (QC) criteria to the genotype data. Genotypes were cleaned before analysis by removing single-nucleotide polymorphisms (SNPs) or individuals not fulfilling the QC criteria. The following QC filters were applied for samples: call rate at least 95%; autosomal heterozygosity between 33 and 37%. At the SNP level, Hardy Weinberg Equilibrium (HWE) with P-value &gt;10<sup>&#8722;4</sup>, Minor Allele Frequency (MAF) at least 1%, and call rate at least 95% for SNPs with MAF 0.05 and above or at least 99% for SNPs with MAF less than 0.05. We further visually inspected all intensity cluster plots of SNPs that showed either an association for over-dispersion of the clusters, biased no calling, or erroneous genotype assignment and discarded all SNPs with any of these characteristics.</p><p>Genotypes from the TwinsUK were imputed using the genotypes from the 3,855,687 autosomal markers available from the HapMap Phase 2 CEPH population <xref rid="pone.0035041-Marcini1" ref-type="bibr">[22]</xref>. After imputation using IMPUTE2 a total of 2,558,978 non-monomorphic&#160;autosomal markers became available. After removing very rare markers (MAF&lt;0.1) and markers in Hardy-Weinberg Disequilibrium (p&lt;e&#8722;6) and individual with poor imputation scores (&lt;0.5), we obtained results from 2,287,762 loci across the chromosome.</p></sec><sec id="s2d"><title>Statistical Analysis</title><p>Of the 1,489 women with recorded phenotype, genotype data was available for 1,104 subjects after QC check. Data handling and preliminary analyses were conducted using STATA software (StataCorp., College Station, TX) and Merlin (PMID 11731797) <xref rid="pone.0035041-Chen1" ref-type="bibr">[23]</xref>. Association analyses were performed using MERLIN. Ancestry was determined through principal component analysis of individual genotypes (compared with subjects participating in the HapMap Phase II standard populations).</p><p>All traits were included in multiple regression models, with age and menopausal state included as covariates. Traits were inverse-normalized to avert undue effects of non-normality of their distributions. Regression slopes (&#946;) are given as numbers of standard deviation units per each additional copy of the effect allele from this point onwards in the text. Given the experimental size with hundreds of thousands of SNPs being analysed individually, the commonly used &#8220;genome wide significance&#8221; (GWS) threshold was used which is the standard approximation routinely set at 5&#215;10<sup>&#8722;8</sup>
<xref rid="pone.0035041-Marcini2" ref-type="bibr">[24]</xref>. However, given the cost of a strict Bonferroni adjustment in results from relatively small datasets, we considered all the associations with P&#8804;5&#215;10<sup>&#8722;5</sup>, as others have done in other studies of similar sizes (UK IBD Genetics Consortium, 2009; Amundadottir et al., 2009) <xref rid="pone.0035041-Dudbridge1" ref-type="bibr">[25]</xref>, <xref rid="pone.0035041-Amundadottir1" ref-type="bibr">[26]</xref>.</p></sec></sec><sec id="s3"><title>Results</title><p>Racial and ethnicity stratification was checked through eigenvector analysis and the above mentioned samples only contained individuals of certified and pure European ancestry. The genotyped samples were tested for population stratification, by comparison to the three HapMap phase 2 reference populations (CEU, YRI, CHB+JPT; <ext-link ext-link-type="uri" xlink:href="http://www.hapmap.org">www.hapmap.org</ext-link>) using principal component analysis.</p><p>The mean age of participants in the study was 57 years (range 25&#8211;81 years). The GWAS analysis was performed using both observed and imputed genotypes. The genomic inflation factor (<italic>&#955;</italic>) ranged from 0.98 to 0.99 for the different phenotypes, showing no evidence for population stratification or inflated results due to imputation. We identified 34SNPs with P-values <underline>&lt;</underline>10<sup>&#8722;5</sup> of association with FSD-related measures. These results are summarized in <xref ref-type="table" rid="pone-0035041-t001">Table 1</xref>. The most significant association was found between rs13202860 on chromosome 6 and sexual arousal, with <italic>P</italic>&#8202;=&#8202;1.2&#215;10<sup>&#8722;7</sup>. Two additional nearby SNPs showed P-values less than 4&#215;10<sup>&#8722;7</sup>, (rs1876525, rs13209281; <italic>P</italic>&#8202;=&#8202;1.2&#215;10<sup>&#8722;7</sup> and 8.3&#215;10<sup>&#8722;7</sup>, respectively; <xref ref-type="table" rid="pone-0035041-t001">Table 1</xref> and <xref ref-type="fig" rid="pone-0035041-g001">Figure 1</xref>). All three SNPs were associated with arousal levels and spanned a region of 11 kb, around 500 kbp upstream from the <italic>HTR1E</italic> (5-hydroxytryptamine receptor 1E) locus (<xref ref-type="fig" rid="pone-0035041-g002">Figure 2</xref> and <xref ref-type="fig" rid="pone-0035041-g003">Figure 3</xref>).</p><fig id="pone-0035041-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0035041.g001</object-id><label>Figure 1</label><caption><title>Manhattan plots describing the association of 2.5 M SNPs with sexual arousal, lubrication and overall sexual functioning.</title><p>SNPs with <italic>P</italic>&#8804;10&#8211;6 are highlighted with a red circle (n&#8202;=&#8202;1104 females).</p></caption><graphic xlink:href="pone.0035041.g001"/></fig><fig id="pone-0035041-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0035041.g002</object-id><label>Figure 2</label><caption><title>Association scatter plot for SNPs in the gene desert approximately 1Mbp upstream of the <italic>HTR1E</italic> gene.</title><p>TwinsUK discovery cohort. Negative logarithms of the P values for the association of each SNP with spherical equivalence are plotted. The lead SNP is plotted in diamond shape, with the GWAS-analysis P value for that SNP indicated. Genotyped SNPs are plotted as squares, with the colour indicating the degree of pairwise LD between the lead and neighbouring SNPs. Red indicates strong pairwise LD, with r2&#8805;0.8; orange indicates moderate LD, with 0.5&lt;r2&lt;0.8 yellow indicates weak LD, with 0.2&lt;r2&lt;0.5; and white indicates no LD, with r2&lt;0.2. The recombination rates are shown as light blue line.</p></caption><graphic xlink:href="pone.0035041.g002"/></fig><fig id="pone-0035041-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0035041.g003</object-id><label>Figure 3</label><caption><title>Haploview LD plot. The plot uses the hapmapPhase3 data on the CEU and the TSI Caucasian populations and encompasses an 800 kbp segment containing the associated SNP on chromosome 6 and <italic>HTR1E</italic>.</title><p>The LD blocks were defined by confidence intervals according to Gabriel and colleagues <xref rid="pone.0035041-Gabriel1" ref-type="bibr">[45]</xref>. The x-axis corresponds to the genomic position in kb and the red triangles defined by black lines represent LD blocks. The yellow arrow and the red box indicate the location of three GWAS associated SNP and the position of <italic>HTR1E</italic>, respectively.</p></caption><graphic xlink:href="pone.0035041.g003"/></fig><table-wrap id="pone-0035041-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0035041.t001</object-id><label>Table 1</label><caption><title>Top SNPs associated with sexual function related measures in a cohort of females of European ancestry.</title></caption><alternatives><graphic id="pone-0035041-t001-1" xlink:href="pone.0035041.t001"/></alternatives><table-wrap-foot><fn id="nt101"><label>*</label><p>Effect, &#946; coefficient of linear regression. The effect sizes denote changes in phenotype unit per each additional copy of the reference allele.</p></fn></table-wrap-foot></table-wrap><p>We also identified a locus on chromosome 22 with multiple adjacent SNPs showing similar, albeit modest levels of associations with overall sexual function (<xref ref-type="table" rid="pone-0035041-t001">Table 1</xref>; <xref ref-type="fig" rid="pone-0035041-g001">Figure 1</xref>). Association was maximal for rs4820255 and rs4821535 (both <italic>P</italic>&#8202;=&#8202;1.2&#215;10<sup>&#8722;6</sup>), two SNP located 344 bp apart within intron 3 of the parvalbumin (<italic>PVALB</italic>) gene. Similarly, six SNPs associated with lubrication levels could be detected (<italic>P</italic>&lt;3&#215;10<sup>&#8722;6</sup> for all) on chromosome 10 near the <italic>EPC1</italic> gene (<xref ref-type="table" rid="pone-0035041-t001">Table 1</xref>; <xref ref-type="fig" rid="pone-0035041-g001">Figure 1</xref>).</p><p>Previous association studies have suggested several potential candidates to be associated with FSD. More specifically, earlier studies identified several variants on the dopamine D4 receptor (<italic>DRD4</italic>) and the serotonin 2A receptor gene (<italic>5HT2A</italic>) to be linked with levels of sexual desire and arousal (14,15). In this GWAS, observed and/or imputed genotype information was available for 2 SNPs in the <italic>DRD4</italic>, 5 SNPS in the <italic>5HT2A</italic> and 3 SNPS in the <italic>IL-1B</italic> gene, and were hence evaluated for the replication of previously reported associations. However, none of the markers showed significant associations with the previously suggested phenotypes (or with any of the outcome variables), as displayed in <xref ref-type="table" rid="pone-0035041-t002">Table 2</xref>.</p><table-wrap id="pone-0035041-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0035041.t002</object-id><label>Table 2</label><caption><title>P-values of available markers in our GWAS, reported to be associated with specific sexual problems in previous candidate gene studies.</title></caption><alternatives><graphic id="pone-0035041-t002-2" xlink:href="pone.0035041.t002"/></alternatives><table-wrap-foot><fn id="nt102"><label>*</label><p>Bonferroni corrected p-value.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4"><title>Discussion</title><p>Here we reported the results of the first ever GWAS of female sexual function levels in an unselected population-based cohort of British women. There were no associations at conventional genome-wide level of significance (P&lt;5&#215;10<sup>&#8722;8</sup>), but we found strongly suggestive associations. Several studies of similar size have considered any association with P-values &#8804;1&#215;10<sup>&#8722;5</sup> as being suggestive <xref rid="pone.0035041-Dudbridge1" ref-type="bibr">[25]</xref>, <xref rid="pone.0035041-Amundadottir1" ref-type="bibr">[26]</xref>. Moreover, numerous suggestive associations below the genome-wide cut-off have been replicated in independent studies, strongly suggesting that these are indeed real associations rather than spurious results. For example, the Genetic Analysis of Psoriasis Consortium &amp; the Wellcome Trust Case Control Consortium 2 in a GWAS study for psoriasis, replicated many of the suggestive associations found by Nair and colleagues including SNP nearby <italic>IL-23A</italic> and <italic>TNFIP3</italic> with <italic>P</italic>&#8804;2&#215;10<sup>&#8722;5</sup> and <italic>P</italic>&#8804;1&#215;10<sup>&#8722;5</sup>, respectively <xref rid="pone.0035041-UKIBDGenetics1" ref-type="bibr">[27]</xref>, <xref rid="pone.0035041-GeneticAnalysisofPsoriasisConsortium1" ref-type="bibr">[28]</xref>. Here, we identified several strong suggestive associations with much stronger levels of significance. Our strongest association (<italic>P</italic> 1.2x10<sup>&#8722;7</sup>), was on the phenotypic dimension of arousal with a serotonin receptor gene (<italic>HTR1E)</italic> which represents a strong biological candidate previously shown to be involved in female sexuality. This potential susceptibility locus resides within a &#8764;1 Mbp segment of the genome devoid of annotated genes, located about 500 kbp downstream of the <italic>HTR1E</italic> gene. To assess the relationship between rs13202860 and <italic>HTR1E</italic> we plotted the LD pattern of the region. HapMap 3 data from two Caucasian populations (CEU and TSI) shows that rs13202860, rs1876525 and rs13209281, which show association with arousal in our study, are located in different LD blocks than <italic>HTR1E</italic> (<xref ref-type="fig" rid="pone-0035041-g003">Figure 3</xref>). Although <italic>HTR1E</italic> is an interesting candidate gene because of its known physiology, the large distance between both loci, together with the evidence that the significant SNP lie in other LD blocks than <italic>HTR1E</italic> clearly suggest that these three SNPs are tagging independent associations and that the causal polymorphism is more likely to regulate gene expression rather than the protein structure of <italic>HTR1E</italic>. Enhancers are elements of the genome that regulate gene expression of nearby or distant genes and which can be located within gene deserts <xref rid="pone.0035041-Nair1" ref-type="bibr">[29]</xref>. Recent research suggests that polymorphisms in gene deserts could impact on disease by altering an enhancer element <xref rid="pone.0035041-Nair1" ref-type="bibr">[29]</xref>&#8211;<xref rid="pone.0035041-Ghoussaini1" ref-type="bibr">[31]</xref>. Thus, it is possible that our causal variant is altering an enhancer element located in the gene desert influencing <italic>HTR1E</italic>.</p><p>
<italic>HTR1E</italic> encodes one of the families of highly conserved serotonin receptor genes and is strongly expressed in neurons, primarily in limbic brain regions (including caudate putamen, claustrum, hippocampus, and amygdala) <xref rid="pone.0035041-Harismendy1" ref-type="bibr">[32]</xref>&#8211;<xref rid="pone.0035041-Barone1" ref-type="bibr">[33]</xref>. This high degree of evolutionary conservation of genetic sequence suggests an important physiological role of the <italic>HTR1E</italic> receptor in humans. However, the actual function of the <italic>HTR1E</italic> receptor remains unknown. Nevertheless, <italic>HTR1E</italic> is a gene with considerable biological relevance to our phenotype of sexual functioning as it shares amino acid sequence homologies and some pharmacological characteristics with other 5-HT receptors (serotonin) and is therefore closely related. Comparative research has documented the critical role of serotonin receptors in modulating human and non-human mammalian sexual behavior and functioning acting on both central and peripheral (genital) sites <xref rid="pone.0035041-ShimronAbarbanell1" ref-type="bibr">[34]</xref>&#8211;<xref rid="pone.0035041-Frohlich1" ref-type="bibr">[35]</xref>. SSRI (selective serotonin reuptake inhibitors)-associated sexual side effects, which include peripheral dysfunctions (e.g., erectile) as well as central problems in desire and arousal are well documented at high prevalence among users (up to 60%) <xref rid="pone.0035041-Zajecka1" ref-type="bibr">[36]</xref>. These post-SSRI sexual dysfunctions (PSSD) point strongly to the involvement of serotonin receptors in human sexual behavior. Central serotonergic activity affects female sexual functioning via limbic projections of serotonin neurotransmitter are co-localized with norepinephrine receptors &#8211; and both transmitters seem to work in conjunction in the regulation of arousal and lubrication <xref rid="pone.0035041-Frohlich1" ref-type="bibr">[35]</xref>, <xref rid="pone.0035041-Frazer1" ref-type="bibr">[37]</xref>. However, the involvement of serotonin receptors in several reward-related behavioral functions (e.g. satiety, sexual behavior, nociception, escape, and stress) suggests that these receptors may function in the &#8220;higher-order&#8221; integration of rewarding behavior.</p><p>Our finding of a putative association between <italic>PVALB</italic> and overall sexual functioning scores on the FSFI-LL is entirely new. <italic>PVALB</italic> is a calcium-binding albumin protein present in GABAergic interneurons, expressed predominantly in the prefrontal cortex. Similar to serotonin, GABA is a major inhibitory neurotransmitter. Several lines of research demonstrate that GABA levels are associated with sexual function. Animal studies show that GABA(A) and GABA(B) receptors are involved in the inhibition of lordosis (a response shown by female animals indicating sexual receptivity) as well as mediating the effects of sex steroids such as estrogen in appetitive sexual behavior (e.g., sexual exploration) <xref rid="pone.0035041-Frazer1" ref-type="bibr">[37]</xref>, <xref rid="pone.0035041-Wada1" ref-type="bibr">[38]</xref>. Elevated levels of stress have also been shown to dampen sexual response in animal models as well as being a significant psychological correlate of FSD in women <xref rid="pone.0035041-Frye1" ref-type="bibr">[39]</xref>, <xref rid="pone.0035041-Kogan1" ref-type="bibr">[40]</xref>. The number of hippocampal PV-containing GABAergic interneurons is highly responsive to chronic external stressors, offering the potential of stress-induced neuro-structural alterations.</p><p>The EPC1 gene encodes the enhancer of polycomb homolog 1 and is a component of the NuA4 histone acetyltransferase complex. Previous research has suggested that this complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, and apoptosis. It has also shown to be involved in skeletal muscle differentiation <xref rid="pone.0035041-Ponholzer1" ref-type="bibr">[41]</xref>, <xref rid="pone.0035041-Doyon1" ref-type="bibr">[42]</xref>. At this stage it is unclear through which mechanisms EPC1 could have an effect on vaginal lubrication and would need to be further investigated.</p><p>The present study had some methodological limitations and the findings should be interpreted with caution. Our study sample consisted mostly of peri- or postmenopausal women (70%). For this reason, representativeness of our study might be limited to the older female population, especially when considering that sexual dysfunction is more common in peri- and postmenopausal than in the non-climacteric period. However, prevalence rates of FSD in our sample are comparable to estimates found in other, younger populations <xref rid="pone.0035041-Burri1" ref-type="bibr">[3]</xref>. Ideally, although similar populations are hard to come by, it would be important to replicate our GWAS findings in larger and independent samples before pursuing research into the underlying biological disease pathways. Our sample size may be one reason why our analysis did not reach conventional levels of GWA significance. Unfortunately, as is common in this field, there are no additional genotyped cohorts available with matching phenotypic data that could have been used to replicate our findings. Common diseases are typically influenced by multiple environmental as well as genetic factors. Our case and control participants may differ systematically for several of these environmental characteristics (e.g. education, anxiety levels, personality) which in turn could theoretically be related to genetic variation and to the disorder itself. Future studies in much larger sample sizes may be able to partition effects of known psychological predictors of FSD (such as sexual distress and anxiety levels) and if family-based differentiate genetic architecture of these co-morbid traits. Current approaches to perform GWAS are most successful if the common disease/common variant (CDCV) assumption holds <xref rid="pone.0035041-Kim1" ref-type="bibr">[43]</xref>. Currently, exome sequencing has proven to be a powerful tool to identify rare coding variants and has the potential to overcome certain GWAS limitations by focusing on the identification of functional genomic structural variants rather than markers. Gene-environment interaction is also likely to have an influence on the development and maintenance of FSD <xref rid="pone.0035041-Bell1" ref-type="bibr">[44]</xref>. In this regard, high throughput sequencing approaches would be again very useful as it can be used to interrogate functional aspects of the genome to identify epigenetic modifications such as DNA methylation, DNA-protein interaction, chromatin accessibility, etc.</p><p>In summary, we report the first GWAS of female sexual dysfunction symptoms in humans. This has pointed to several &#8220;risk alleles&#8221; and the implication of the serotonin and GABA pathways which we hope encourages further replication in large and independent population-based cohorts and then biological investigation to elucidate possible mechanisms. Ultimately, understanding key mechanisms via this research may lead to new FSD treatments and inform clinical practice and developments in psychiatric nosology.</p></sec></body><back><ack><p>We thank the staff from the Genotyping Facilities at the Wellcome Trust Sanger Institute led by Leena Peltonen and Panos Deloukas, for sample preparation, quality control, and genotyping; Le Centre National de Genotypage, France, led by Mark Lathrop, for genotyping; Duke University, North Carolina, USA, led by David Goldstein, for genotyping; and the Finnish Institute of Molecular Medicine, Finnish Genome Center, University of Helsinki, led by Aarno Palotie.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>The authors acknowledge financial support from the Wellcome Trust; the National Eye Institute via an National Institutes of Health/Center for Inherited Disease Research (NIH/CIDR) genotyping project; the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy&#8217;s &amp; St Thomas&#8217; National Health Service (NHS) Foundation Trust in partnership with King&#8217;s College London; and the Chronic Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group><ref-list><title>References</title><ref id="pone.0035041-Laumann1"><label>1</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Laumann</surname><given-names>EO</given-names></name><name><surname>Paik</surname><given-names>A</given-names></name><name><surname>Rosen</surname><given-names>RC</given-names></name></person-group>
<year>1999</year>
<article-title>Sexual Dysfunction in the United States. Prevalence and predictors.</article-title>
<source><italic>JAMA</italic></source>
<volume>281</volume>
<fpage>537</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="pmid">10022110</pub-id></element-citation></ref><ref id="pone.0035041-Rosen1"><label>2</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosen</surname><given-names>RC</given-names></name><name><surname>Taylor</surname><given-names>JF</given-names></name><name><surname>Leiblum</surname><given-names>SR</given-names></name><name><surname>Bachmann</surname><given-names>GA</given-names></name></person-group>
<year>1993</year>
<article-title>Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic.</article-title>
<source><italic>J Sex Marital Ther</italic></source>
<volume>19</volume>
<fpage>171</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="pmid">8246273</pub-id></element-citation></ref><ref id="pone.0035041-Burri1"><label>3</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burri</surname><given-names>A</given-names></name><name><surname>Spector</surname><given-names>T</given-names></name></person-group>
<year>2011</year>
<article-title>Recent and lifelong sexual dysfunctions in a female UK population sample: prevalence and risk factors.</article-title>
<source><italic>J Sex Med</italic></source>
<volume>8</volume>
<fpage>2420</fpage>
<lpage>2430</lpage>
<pub-id pub-id-type="pmid">21676186</pub-id></element-citation></ref><ref id="pone.0035041-Derogatis1"><label>4</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Derogatis</surname><given-names>LR</given-names></name><name><surname>Burnett</surname><given-names>AL</given-names></name></person-group>
<year>2008</year>
<article-title>The epidemiology of sexual dysfunctions.</article-title>
<source>J <italic>Sex Med</italic></source>
<volume>5</volume>
<fpage>289</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="pmid">18004994</pub-id></element-citation></ref><ref id="pone.0035041-Hawton1"><label>5</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hawton</surname><given-names>DM</given-names></name><name><surname>Gath</surname><given-names>D</given-names></name><name><surname>Day</surname><given-names>A</given-names></name></person-group>
<year>2000</year>
<article-title>Sexual Function in a Community Sample of Middle-Aged Women with Partners: Effects of Age, Marital, Socioeconomic, Psychiatric, Gynecological, and Menopausal Factors.</article-title>
<source><italic>Arch Sex Behav</italic></source>
<volume>23</volume>
<fpage>375</fpage>
<lpage>395</lpage>
</element-citation></ref><ref id="pone.0035041-Basson1"><label>6</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basson</surname><given-names>R</given-names></name><name><surname>Berman</surname><given-names>J</given-names></name><name><surname>Burnett</surname><given-names>A</given-names></name><name><surname>Derogatis</surname><given-names>L</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>Report of the international consensus development conference on female sexual dysfunction: Definitions and classifications.</article-title>
<source><italic>J Urol</italic></source>
<volume>163</volume>
<fpage>888</fpage>
<lpage>893</lpage>
<pub-id pub-id-type="pmid">10688001</pub-id></element-citation></ref><ref id="pone.0035041-Basson2"><label>7</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basson</surname><given-names>R</given-names></name><name><surname>Althof</surname><given-names>S</given-names></name><name><surname>David</surname><given-names>S</given-names></name><name><surname>Fugl-Meyer</surname><given-names>K</given-names></name><name><surname>Goldstein</surname><given-names>I</given-names></name></person-group>
<year>2004</year>
<article-title>Summary of the recommendations on sexual dysfunctions in women.</article-title>
<source><italic>J Sex Med</italic></source>
<volume>1</volume>
<fpage>24</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">16422980</pub-id></element-citation></ref><ref id="pone.0035041-Witting1"><label>8</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Witting</surname><given-names>K</given-names></name><name><surname>Santilla</surname><given-names>P</given-names></name><name><surname>Rijsdijk</surname><given-names>F</given-names></name><name><surname>Varjonen</surname><given-names>M</given-names></name><name><surname>Stern</surname><given-names>P</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Correlated genetic and non-shared environmental influences account for the comorbidity between female sexual dysfunctions.</article-title>
<source><italic>Psychol Med</italic></source>
<volume>26</volume>
<fpage>1</fpage>
<lpage>13</lpage>
</element-citation></ref><ref id="pone.0035041-Dawood1"><label>9</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dawood</surname><given-names>K</given-names></name><name><surname>Kirk</surname><given-names>KM</given-names></name><name><surname>Bailey</surname><given-names>JM</given-names></name><name><surname>Andrews</surname><given-names>PW</given-names></name><name><surname>Martin</surname><given-names>NG</given-names></name></person-group>
<year>2008</year>
<article-title>Genetic and environmental influences on the frequency of orgasm in women.</article-title>
<source><italic>Twin Res Hum Genet</italic></source>
<volume>8</volume>
<fpage>27</fpage>
<lpage>33</lpage>
</element-citation></ref><ref id="pone.0035041-Dunn1"><label>10</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dunn</surname><given-names>KM</given-names></name><name><surname>Cherkas</surname><given-names>LF</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group>
<year>2005</year>
<article-title>Genetic on variation in female orgasmic function: A twin study.</article-title>
<source><italic>Biol Lett</italic></source>
<volume>22</volume>
<fpage>260</fpage>
<lpage>26</lpage>
</element-citation></ref><ref id="pone.0035041-Hettema1"><label>11</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hettema</surname><given-names>JM</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name></person-group>
<year>2001</year>
<article-title>A review and meta-analysis of the genetic epidemiology of anxiety disorders.</article-title>
<source><italic>Am J Psychiatr</italic></source>
<volume>158</volume>
<fpage>1568</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">11578982</pub-id></element-citation></ref><ref id="pone.0035041-Sullivan1"><label>12</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>PF</given-names></name><name><surname>Neale</surname><given-names>MC</given-names></name><name><surname>Kendler</surname><given-names>KS</given-names></name></person-group>
<year>2000</year>
<article-title>Genetic epidemiology of major depression: review and meta-analysis.</article-title>
<source><italic>Am J Psychiatr</italic></source>
<volume>157</volume>
<fpage>1552</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="pmid">11007705</pub-id></element-citation></ref><ref id="pone.0035041-Jang1"><label>13</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jang</surname><given-names>K</given-names></name><name><surname>Wesley</surname><given-names>WJ</given-names></name><name><surname>Vemon</surname><given-names>PA</given-names></name></person-group>
<year>1996</year>
<article-title>Heritability of the Big Five Personality Dimensions and Their Facets: A Twin Study.</article-title>
<source><italic>J of Pers</italic></source>
<volume>64</volume>
<fpage>577</fpage>
<lpage>591</lpage>
<pub-id pub-id-type="pmid">8776880</pub-id></element-citation></ref><ref id="pone.0035041-Bishop1"><label>14</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bishop</surname><given-names>JR</given-names></name><name><surname>Moline</surname><given-names>J</given-names></name><name><surname>Ellingrod</surname><given-names>VL</given-names></name><name><surname>Schultz</surname><given-names>SK</given-names></name><name><surname>Clayton</surname><given-names>AH</given-names></name></person-group>
<year>2006</year>
<article-title>Serotonin 2A-1438 G/A and G-protein Beta3 subunit C825T polymorphismms in patients with depression and SSRI-associated sexual side-effects.</article-title>
<source><italic>Neuropsychopharmacol</italic></source>
<volume>31</volume>
<fpage>2281</fpage>
<lpage>2288</lpage>
</element-citation></ref><ref id="pone.0035041-BenZion1"><label>15</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ben Zion</surname><given-names>IZ</given-names></name><name><surname>Tessler</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>L</given-names></name><name><surname>Lerer</surname><given-names>E</given-names></name><name><surname>Raz</surname><given-names>Y</given-names></name><name><surname>Bachner- Melman</surname><given-names>R</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function.</article-title>
<source><italic>Mol Psychiatry</italic></source>
<volume>11</volume>
<fpage>782</fpage>
<lpage>786</lpage>
<pub-id pub-id-type="pmid">16619053</pub-id></element-citation></ref><ref id="pone.0035041-Gerber1"><label>16</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gerber</surname><given-names>S</given-names></name><name><surname>Bongiovanni</surname><given-names>AM</given-names></name><name><surname>Ledger</surname><given-names>WJ</given-names></name><name><surname>Witkin</surname><given-names>SS</given-names></name></person-group>
<year>2003</year>
<article-title>Interleukin- 1beta gene polymorphism in women with vulvar vestibulitis syndrome.</article-title>
<source>Eur J Obstet Gynecol <italic>Reprod Biol</italic></source>
<volume>107</volume>
<fpage>74</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">12593899</pub-id></element-citation></ref><ref id="pone.0035041-Spector1"><label>17</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spector</surname><given-names>T</given-names></name><name><surname>Williams</surname><given-names>F</given-names></name></person-group>
<year>2006</year>
<article-title>The UK Adult Twin Registry (TwinsUK).</article-title>
<source><italic>Twin Res Hum Genet</italic></source>
<volume>9</volume>
<fpage>899</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="pmid">17254428</pub-id></element-citation></ref><ref id="pone.0035041-Andrews1"><label>18</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andrews</surname><given-names>T</given-names></name><name><surname>Hart</surname><given-names>DJ</given-names></name><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>de Lange</surname><given-names>M</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Are twins and singletons comparable? A study of disease-related and lifestyle characteristics.</article-title>
<source><italic>Twin Res Hum Genet</italic></source>
<volume>4</volume>
<fpage>464</fpage>
<lpage>77</lpage>
</element-citation></ref><ref id="pone.0035041-Snieder1"><label>19</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Snieder</surname><given-names>H</given-names></name><name><surname>MacGregor</surname><given-names>AJ</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group>
<year>1998</year>
<article-title>Genes control the cessation of a woman&#8217;s reproductive life: a twin study of hysterectomy and age at menopause.</article-title>
<source><italic>J Clin Endocrinol Metab</italic></source>
<volume>83</volume>
<fpage>1875</fpage>
<lpage>1880</lpage>
<pub-id pub-id-type="pmid">9626112</pub-id></element-citation></ref><ref id="pone.0035041-Rosen2"><label>20</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosen</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>C</given-names></name><name><surname>Heiman</surname><given-names>J</given-names></name><name><surname>Leiblum</surname><given-names>S</given-names></name><name><surname>Meston</surname><given-names>C</given-names></name><etal/></person-group>
<year>2000</year>
<article-title>The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.</article-title>
<source><italic>J Sex Mar Ther</italic></source>
<volume>26</volume>
<fpage>191</fpage>
<lpage>208</lpage>
</element-citation></ref><ref id="pone.0035041-Burri2"><label>21</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burri</surname><given-names>A</given-names></name><name><surname>Cherkas</surname><given-names>L</given-names></name><name><surname>Spector</surname><given-names>T</given-names></name></person-group>
<year>2010</year>
<article-title>Replication of psychometric properties of the FSFI and validation of a modified version (FSFI-LL) assessing lifelong sexual function in an unselected sample of females.</article-title>
<source><italic>J Sex Med</italic></source>
<volume>7</volume>
<fpage>3929</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="pmid">20722783</pub-id></element-citation></ref><ref id="pone.0035041-Marcini1"><label>22</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marcini</surname><given-names>J</given-names></name><name><surname>Howie</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group>
<year>2009</year>
<article-title>A new multipoint method for genome-wide association studies via imputation of genotypes.</article-title>
<source><italic>Nat Genet</italic></source>
<volume>39</volume>
<fpage>906</fpage>
<lpage>913</lpage>
</element-citation></ref><ref id="pone.0035041-Chen1"><label>23</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>WM</given-names></name><name><surname>Abecasis</surname><given-names>R</given-names></name></person-group>
<year>2007</year>
<article-title>Family-based association tests for genomewide association scans.</article-title>
<source><italic>Am J Hum Genet</italic></source>
<volume>81</volume>
<fpage>913</fpage>
<lpage>26</lpage>
<pub-id pub-id-type="pmid">17924335</pub-id></element-citation></ref><ref id="pone.0035041-Marcini2"><label>24</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marcini</surname><given-names>J</given-names></name><name><surname>Howie</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group>
<year>2009</year>
<article-title>A new multipoint method for genome-wide association studies via imputation of genotypes.</article-title>
<source><italic>Nat Genet</italic></source>
<volume>39</volume>
<fpage>906</fpage>
<lpage>913</lpage>
</element-citation></ref><ref id="pone.0035041-Dudbridge1"><label>25</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dudbridge</surname><given-names>F</given-names></name><name><surname>Gusnanto</surname><given-names>A</given-names></name></person-group>
<year>2008</year>
<article-title>Estimation of significance thresholds for genomewide association scans.</article-title>
<source><italic>Genet Epidemiol</italic></source>
<volume>32</volume>
<fpage>227</fpage>
<lpage>234</lpage>
<pub-id pub-id-type="pmid">18300295</pub-id></element-citation></ref><ref id="pone.0035041-Amundadottir1"><label>26</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amundadottir</surname><given-names>L</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Stolzenberg-Solomon</surname><given-names>RZ</given-names></name><name><surname>Fuchs</surname><given-names>CS</given-names></name><name><surname>Petersen</surname><given-names>GM</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.</article-title>
<source><italic>Nat Genet</italic></source>
<volume>49</volume>
<fpage>986</fpage>
<lpage>90</lpage>
</element-citation></ref><ref id="pone.0035041-UKIBDGenetics1"><label>27</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>UK IBD Genetics</surname><given-names>Consortium</given-names></name><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Lees</surname><given-names>CW</given-names></name><name><surname>Prescott</surname><given-names>NJ</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region.</article-title>
<source><italic>Nat Genet</italic></source>
<volume>41</volume>
<fpage>1330</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">19915572</pub-id></element-citation></ref><ref id="pone.0035041-GeneticAnalysisofPsoriasisConsortium1"><label>28</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Genetic Analysis of Psoriasis Consortium</surname></name><name><surname>the Wellcome Trust Case Control Consortium</surname><given-names>2</given-names></name><name><surname>Strange</surname><given-names>A</given-names></name><name><surname>Capon</surname><given-names>F</given-names></name><name><surname>Spencer</surname><given-names>CC</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.</article-title>
<source><italic>Nat Genet</italic></source>
<volume>42</volume>
<fpage>985</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="pmid">20953190</pub-id></element-citation></ref><ref id="pone.0035041-Nair1"><label>29</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nair</surname><given-names>RP</given-names></name><name><surname>Duffin</surname><given-names>KC</given-names></name><name><surname>Helms</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Stuart</surname><given-names>PE</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>: Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways.</article-title>
<source><italic>Nat Genet</italic></source>
<volume>41</volume>
<fpage>199</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="pmid">19169254</pub-id></element-citation></ref><ref id="pone.0035041-Wasserman1"><label>30</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>NF</given-names></name><name><surname>Aneas</surname><given-names>I</given-names></name><name><surname>Nobrega</surname><given-names>MA</given-names></name></person-group>
<year>2010</year>
<article-title>An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.</article-title>
<source><italic>Genome Res</italic></source>
<volume>20</volume>
<fpage>1191</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="pmid">20627891</pub-id></element-citation></ref><ref id="pone.0035041-Ghoussaini1"><label>31</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghoussaini</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Koessler</surname><given-names>T</given-names></name><name><surname>Al Olama</surname><given-names>AA</given-names></name><name><surname>Kote-Jarai</surname><given-names>Z</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons&#8217; Section of Oncology; UK ProtecT Study Collaborators. Multiple loci with different cancer specificities within the 8q24 gene desert.</article-title>
<source><italic>J Natl Cancer Inst</italic></source>
<volume>100</volume>
<fpage>962</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="pmid">18577746</pub-id></element-citation></ref><ref id="pone.0035041-Harismendy1"><label>32</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Harismendy</surname><given-names>O</given-names></name><name><surname>Notani</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Rahim</surname><given-names>NG</given-names></name><name><surname>Tanasa</surname><given-names>B</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>9p21 DNA variants associated with coronary artery disease impair interferon-&#947; signalling response.</article-title>
<source><italic>Nature</italic></source>
<volume>470</volume>
<fpage>264</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="pmid">21307941</pub-id></element-citation></ref><ref id="pone.0035041-Barone1"><label>33</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barone</surname><given-names>P</given-names></name><name><surname>Jordan</surname><given-names>D</given-names></name><name><surname>Atger</surname><given-names>F</given-names></name><name><surname>Kopp</surname><given-names>N</given-names></name><name><surname>Fillion</surname><given-names>G</given-names></name></person-group>
<year>1994</year>
<article-title>Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain.</article-title>
<source><italic>Brain Res</italic></source>
<volume>638</volume>
<fpage>85</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">8199879</pub-id></element-citation></ref><ref id="pone.0035041-ShimronAbarbanell1"><label>34</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimron-Abarbanell</surname><given-names>D</given-names></name><name><surname>Nothen</surname><given-names>MM</given-names></name><name><surname>Erdmann</surname><given-names>J</given-names></name><name><surname>Propping</surname><given-names>P</given-names></name></person-group>
<year>1995</year>
<article-title>: Lack of genetically determined structural variants of the human serotonin-1E (5-HT1E) receptor protein points to its evolutionary conservation.</article-title>
<source><italic>Mol Brain Res</italic></source>
<volume>29</volume>
<fpage>387</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="pmid">7609628</pub-id></element-citation></ref><ref id="pone.0035041-Frohlich1"><label>35</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frohlich</surname><given-names>PF</given-names></name><name><surname>Meston</surname><given-names>CM</given-names></name></person-group>
<year>2000</year>
<article-title>Evidence that serotonin affects female sexual functioning via peripheral mechanisms.</article-title>
<source><italic>Physiol Behav</italic></source>
<volume>71</volume>
<fpage>383</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">11150571</pub-id></element-citation></ref><ref id="pone.0035041-Zajecka1"><label>36</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zajecka</surname><given-names>J</given-names></name></person-group>
<year>2001</year>
<article-title>Strategies for the treatment of antidepressant-related sexual dysfunction.</article-title>
<source><italic>J Clin Psychiatry</italic></source>
<volume>62</volume>
<fpage>35</fpage>
<lpage>43</lpage>
</element-citation></ref><ref id="pone.0035041-Frazer1"><label>37</label><element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Frazer</surname><given-names>A</given-names></name><name><surname>Hensler</surname><given-names>JG</given-names></name></person-group>
<year>1999</year>
<article-title>Serotonin.</article-title>
<person-group person-group-type="editor"><name><surname>GJ</surname><given-names>InSiegel</given-names></name><name><surname>BW</surname><given-names>Agranoff</given-names></name><name><surname>RW</surname><given-names>Albers</given-names></name><name><surname>FisherSK</surname></name></person-group>
<source>Uhler MD (eds.)</source>
<publisher-loc>Basic Neurochemistry. Lippincott-Raven</publisher-loc>
<publisher-name>Philadelphia, PA</publisher-name>
</element-citation></ref><ref id="pone.0035041-Wada1"><label>38</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wada</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>S</given-names></name><name><surname>Yamanouchi</surname><given-names>K</given-names></name></person-group>
<year>2008</year>
<article-title>Additive inhibition of lordosis by simultaneous treatments with GABA(A) and GABA(B) receptor agonists, muscimol and baclofen, in female rats.</article-title>
<source>Pharmacol <italic>Biochem Res</italic></source>
<volume>90</volume>
<fpage>590</fpage>
<lpage>3</lpage>
</element-citation></ref><ref id="pone.0035041-Frye1"><label>39</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frye</surname><given-names>CA</given-names></name><name><surname>Paris</surname><given-names>JJ</given-names></name></person-group>
<year>2011</year>
<article-title>Effects of neurosteroid actions at N-methyl-D-aspartate and GABA A receptors in the midbrain ventral tegmental area for anxiety-like and mating behavior of female rats.</article-title>
<source><italic>Psychopharmacology</italic></source>
<volume>213</volume>
<fpage>93</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="pmid">20878318</pub-id></element-citation></ref><ref id="pone.0035041-Kogan1"><label>40</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kogan</surname><given-names>MI</given-names></name><name><surname>Kalinchenko</surname><given-names>SI</given-names></name><name><surname>Avadieva</surname><given-names>NE</given-names></name></person-group>
<year>2009</year>
<article-title>Sexual dysfunction in Russia: risk factors for women.</article-title>
<source>Urologiia</source>
<volume>5</volume>
<fpage>8</fpage>
<lpage>12</lpage>
</element-citation></ref><ref id="pone.0035041-Ponholzer1"><label>41</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ponholzer</surname><given-names>A</given-names></name><name><surname>Roehlich</surname><given-names>M</given-names></name><name><surname>Racz</surname><given-names>U</given-names></name><name><surname>Temml</surname><given-names>C</given-names></name><name><surname>Madersbacher</surname><given-names>S</given-names></name></person-group>
<year>2005</year>
<article-title>Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors.</article-title>
<source>Eur <italic>Urol</italic></source>
<volume>47</volume>
<fpage>366</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">15716203</pub-id></element-citation></ref><ref id="pone.0035041-Doyon1"><label>42</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doyon</surname><given-names>Y</given-names></name><name><surname>Selleck</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name></person-group>
<year>2004</year>
<article-title>Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.</article-title>
<source><italic>Mol Cell Biol</italic></source>
<volume>24</volume>
<fpage>1884</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="pmid">14966270</pub-id></element-citation></ref><ref id="pone.0035041-Kim1"><label>43</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>JR</given-names></name><name><surname>Kee</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Joung</surname><given-names>H</given-names></name><name><surname>Nam</surname><given-names>KI</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Enhancer of polycomb1 acts on serum response factor to regulate skeletal muscle differentiation.</article-title>
<source><italic>J Biol Chem</italic></source>
<volume>284</volume>
<fpage>16308</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="pmid">19359245</pub-id></element-citation></ref><ref id="pone.0035041-Bell1"><label>44</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bell</surname><given-names>JT</given-names></name><name><surname>Spector</surname><given-names>TD</given-names></name></person-group>
<year>2011</year>
<article-title>A twin approach to unraveling epigenetics.</article-title>
<source><italic>Trends in Genetics</italic></source>
<volume>27</volume>
<fpage>116</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="pmid">21257220</pub-id></element-citation></ref><ref id="pone.0035041-Gabriel1"><label>45</label><element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Schaffner</surname><given-names>SF</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Moore</surname><given-names>JM</given-names></name><name><surname>Roy</surname><given-names>J</given-names></name><etal/></person-group>
<year>2002</year>
<article-title>The structure of haplotype blocks in the human genome.</article-title>
<source><italic>Science</italic></source>
<volume>296</volume>
<fpage>2225</fpage>
<lpage>2229</lpage>
<pub-id pub-id-type="pmid">12029063</pub-id></element-citation></ref></ref-list></back></article>